COVID-19 Research Grants in India

COVID-19 Research Grants in India

The Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) announce COVID-19 Research Consortium and seek Letters of Intent (LOIs) with a focus on Diagnostics, Vaccines, Novel Therapeutics, Repurposing of Drugs or any other intervention for control of COVID-19.

In response to the outbreak, there is an urgent need to accelerate development of diagnostics, vaccines, novel therapeutics and repurposing of drugs for this novel corona virus.

In view of the limited current level of knowledge about the new virus, critical research questions need to be answered urgently, and ways have to be found to fund priority research that can contribute to curtail this outbreak and prepare for future outbreaks.

Urgent need to develop safe and effective countermeasures that can be available, accessible and suitable for use in populations most in need.

Research is an important integral component of the response to be able to identify key knowledge gaps and research priorities, and thereby accelerate the generation of critical scientific information and the most needed medical products to contribute to the control of 2019-nCoV emergency.

Themes

The themes of the current RFP is:

Developing Diagnostics, Vaccines, novel Therapeutics, repurposing of drugs and any other intervention for control of COVID-19 outbreak”.

Projects submitted must take into account the criteria for affordability, wide-spread adoption and have a realistic possibility for scale-up.

The scope of the RFP is inclusive and not exhaustive of the following areas:

Diagnostics: